EUVIMEDEUVIMED entdecken
Open Access

Integrative Machine Learning and Experimental Validation Identify MYBL2 as a Prognostic Biomarker and Therapeutic Target in Hepatocellular Carcinoma

Ya-Ling Yang, Ying-Hsien Huang, Hung-Yu Lin

Oncology Research · 2026

DOI: 10.32604/or.2026.075284 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Research, 2026. Verfasst von Ya-Ling Yang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Biomarkers, Tumor, Cell Cycle Proteins. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsBiomarkers, TumorCell Cycle ProteinsMachine LearningHumansAnimalsPrognosisMiceProto-Oncogene MasMicroRNAsGene Expression Regulation, NeoplasticSorafenibMaleMice, TransgenicHep G2 CellsTrans-Activators

Stichwörter der Autor:innen

Hepatocellular carcinomaMYBL2biomarkermiR-29aprecision medicineprognosistumor microenvironment

Substanzen

Biomarkers, TumorMYBL2 protein, humanCell Cycle ProteinsMAS1 protein, humanProto-Oncogene MasMicroRNAsSorafenibMIRN29a microRNA, humanTrans-Activators

Autor:innen und Institutionen

  • Department of Anesthesiology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan.
  • Department of Pediatrics, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan.
  • Department of Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University, Taichung, Taiwan.
  • Research Assistant Center, Show Chwan Memorial Hospital, Changhua, Taiwan.

Zitieren

APA

Yang, Y. L., Huang, Y. H., & Lin, H. Y. (2026). Integrative Machine Learning and Experimental Validation Identify MYBL2 as a Prognostic Biomarker and Therapeutic Target in Hepatocellular Carcinoma. Oncology Research. https://doi.org/10.32604/or.2026.075284

Vancouver

Yang YL, Huang YH, Lin HY. Integrative Machine Learning and Experimental Validation Identify MYBL2 as a Prognostic Biomarker and Therapeutic Target in Hepatocellular Carcinoma. Oncology Research. 2026. doi:10.32604/or.2026.075284

BibTeX
@article{Yang2026,
  author = {Yang, Ya-Ling and Huang, Ying-Hsien and Lin, Hung-Yu},
  title = {Integrative Machine Learning and Experimental Validation Identify MYBL2 as a Prognostic Biomarker and Therapeutic Target in Hepatocellular Carcinoma},
  journal = {Oncology Research},
  year = {2026},
  doi = {10.32604/or.2026.075284}
}
Kostenlos starten →